SXI Life Sciences
7.785,82
PKT
+6,91
PKT
+0,09
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.17 | Roche overweight | Morgan Stanley | |
| 02.02.17 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.17 | Roche buy | Deutsche Bank AG | |
| 02.02.17 | Roche Hold | HSBC | |
| 01.02.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.17 | Roche Hold | Baader Bank | |
| 31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | UBS AG | |
| 30.01.17 | Novartis buy | HSBC | |
| 26.01.17 | Novartis Underweight | Morgan Stanley | |
| 26.01.17 | Novartis Hold | Deutsche Bank AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 25.01.17 | Novartis Outperform | Bernstein Research | |
| 25.01.17 | Novartis buy | Baader Bank | |
| 24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.01.17 | Roche overweight | Morgan Stanley | |
| 12.01.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.01.17 | Roche buy | Deutsche Bank AG | |
| 09.01.17 | Novartis Hold | Deutsche Bank AG | |
| 09.01.17 | Roche buy | Deutsche Bank AG | |
| 03.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 03.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 22.12.16 | Roche buy | UBS AG | |
| 21.12.16 | Roche buy | Deutsche Bank AG | |
| 21.12.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.12.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.12.16 | Novartis Hold | Deutsche Bank AG | |
| 13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis buy | HSBC | |
| 08.12.16 | Roche buy | UBS AG | |
| 08.12.16 | Novartis Neutral | UBS AG | |
| 07.12.16 | Roche buy | Deutsche Bank AG | |
| 06.12.16 | Roche overweight | JP Morgan Chase & Co. |